DrugPatentWatch Database Preview

Dow Pharm Company Profile

DOW PHARM has nine approved drugs.

There is one US patent protecting DOW PHARM drugs.

There are twenty-eight patent family members on DOW PHARM drugs in twenty-two countries and eighteen supplementary protection certificates in thirteen countries.

International Patents:	28
US Patents:	1
Tradenames:	7
Ingredients:	7
NDAs:	9
Patent Litigation for Dow Pharm:	See patent lawsuits for Dow Pharm

Subscribe to access the full database, or Start Trial
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Exclusivity Expiration
Dow Pharm	NEO-POLYCIN	bacitracin zinc; neomycin sulfate; polymyxin b sulfate	OINTMENT;OPHTHALMIC	060647-001	Approved Prior to Jan 1, 1982		DISCN	No	No		Start Trial				Start Trial
Dow Pharm	ALTRENO	tretinoin	LOTION;TOPICAL	209353-001	Aug 23, 2018		RX	Yes	Yes		Start Trial				Start Trial
Dow Pharm	QUIDE	piperacetazine	TABLET;ORAL	013615-001	Approved Prior to Jan 1, 1982		DISCN	No	No		Start Trial				Start Trial
Dow Pharm	NEO-POLYCIN	gramicidin; neomycin sulfate; polymyxin b sulfate	SOLUTION/DROPS;OPHTHALMIC	060427-001	Approved Prior to Jan 1, 1982		DISCN	No	No		Start Trial				Start Trial
Dow Pharm	NUTRACORT	hydrocortisone	LOTION;TOPICAL	080443-003	Approved Prior to Jan 1, 1982		DISCN	No	No		Start Trial				Start Trial
Dow Pharm	NUTRACORT	hydrocortisone	LOTION;TOPICAL	080443-002	Approved Prior to Jan 1, 1982		DISCN	No	No		Start Trial				Start Trial
>Applicant	>Tradename	>Generic Name	>Dosage	>NDA	>Approval Date	>TE	>Type	>RLD	>RS	>Patent No.	>Patent Expiration	>Product	>Substance	>Delist Req.	>Exclusivity Expiration

Subscribe to access the full database, or Start Trial
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	Patent No.	Patent Expiration
Dow Pharm	ATRALIN	tretinoin	GEL;TOPICAL	022070-001	Jul 26, 2007	5,670,547	Start Trial
>Applicant	>Tradename	>Generic Name	>Dosage	>NDA	>Approval Date	>Patent No.	>Patent Expiration

Subscribe to access the full database, or Start Trial
Patent Number	Supplementary Protection Certificate	SPC Country	SPC Expiration	SPC Description
1304992	1390049-3	Sweden	Start Trial	PRODUCT NAME: KLINDAMYCIN (SOM KLINDAMYCINFOSFAT) OCH TRETINOIN; NAT. REG. NO/DATE: MTNR 46193 20130503; FIRST REG.: IR PA1332/043/001 20130322
0809498	10C0038	France	Start Trial	PRODUCT NAME: ACYCLOVIR ET HYDROCORTISONE; NAT. REGISTRATION NO/DATE: NL 36 826 20100420; FIRST REGISTRATION: SK - 2108/08467-R 20091026
1304992	2013/044	Ireland	Start Trial	PRODUCT NAME: CLINDAMYCIN AND TRETINOIN; REGISTRATION NO/DATE: PA1332/043/001 20130322
1304992	92401	Luxembourg	Start Trial	PRODUCT NAME: CLINDAMYCINE(EN TANT QUE PHOPSHATE DE CLINDAMYCINE)ET TRETINOINE
1304992	474	Finland	Start Trial
1304992	2013C/060	Belgium	Start Trial	PRODUCT NAME: CLINDAMYCINE (ALS CLINDAMYCINE FOSFAAT) EN TRETINOINE; AUTHORISATION NUMBER AND DATE: BE437507 20130506
>Patent Number	>Supplementary Protection Certificate	>SPC Country	>SPC Expiration	>SPC Description

Applicants may be listed under multiple names.
Here is a list of applicants with similar names.